{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:40:13Z","timestamp":1781919613102,"version":"3.54.5"},"reference-count":44,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Open Access Publication Fund of the University of Bonn","award":["FOR2372"],"award-info":[{"award-number":["FOR2372"]}]},{"name":"Open Access Publication Fund of the University of Bonn","award":["SFB1328"],"award-info":[{"award-number":["SFB1328"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG)","award":["FOR2372"],"award-info":[{"award-number":["FOR2372"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG)","award":["SFB1328"],"award-info":[{"award-number":["SFB1328"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Blockade of the adenosine A2B receptor (A2BAR) represents a potential novel strategy for the immunotherapy of cancer. In the present study, we designed, synthesized, and characterized irreversible A2BAR antagonists based on an 8-p-sulfophenylxanthine scaffold. Irreversible binding was confirmed in radioligand binding and bioluminescence resonance energy transfer(BRET)-based G\u03b115 protein activation assays by performing ligand wash-out and kinetic experiments. p-(1-Propylxanthin-8-yl)benzene sulfonyl fluoride (6a, PSB-21500) was the most potent and selective irreversible A2BAR antagonist of the present series with an apparent Ki value of 10.6 nM at the human A2BAR and &gt;38-fold selectivity versus the other AR subtypes. The corresponding 3-cyclopropyl-substituted xanthine derivative 6c (PSB-21502) was similarly potent, but was non-selective versus A1- and A2AARs. Attachment of a reactive sulfonyl fluoride group to an elongated xanthine 8-substituent (12, Ki 7.37 nM) resulted in a potent, selective, reversibly binding antagonist. Based on previous docking studies, the lysine residue K2697.32 was proposed to react with the covalent antagonists. However, the mutant K269L behaved similarly to the wildtype A2BAR, indicating that 6a and related irreversible A2BAR antagonists do not interact with K2697.32. The new irreversible A2BAR antagonists will be useful tools and have the potential to be further developed as therapeutic drugs.<\/jats:p>","DOI":"10.3390\/molecules27123792","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T06:31:59Z","timestamp":1655101919000},"page":"3792","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Irreversible Antagonists for the Adenosine A2B Receptor"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3862-5359","authenticated-orcid":false,"given":"Ahmed","family":"Temirak","sequence":"first","affiliation":[{"name":"PharmaCenter Bonn & Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-0872","authenticated-orcid":false,"given":"Jonathan G.","family":"Schlegel","sequence":"additional","affiliation":[{"name":"PharmaCenter Bonn & Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0595-4607","authenticated-orcid":false,"given":"Jan H.","family":"Voss","sequence":"additional","affiliation":[{"name":"PharmaCenter Bonn & Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-5647","authenticated-orcid":false,"given":"Victoria J.","family":"Vaa\u00dfen","sequence":"additional","affiliation":[{"name":"PharmaCenter Bonn & Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Vielmuth","sequence":"additional","affiliation":[{"name":"PharmaCenter Bonn & Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8186-107X","authenticated-orcid":false,"given":"Tobias","family":"Claff","sequence":"additional","affiliation":[{"name":"PharmaCenter Bonn & Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6624","authenticated-orcid":false,"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"PharmaCenter Bonn & Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/pharmrev.121.000445","article-title":"International Union of Basic and Clinical Pharmacology. CXII: Adenosine receptors: A further update","volume":"74","author":"IJzerman","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pereira-Figueiredo, D., Nascimento, A.A., Cunha-Rodrigues, M.C., Brito, R., and Calaza, K.C. (2021). Caffeine and its neuroprotective role in ischemic events: A mechanism dependent on adenosine receptors. Cell. Mol. Neurobiol.","DOI":"10.1007\/s10571-021-01077-4"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/ene.15103","article-title":"Aspirin, paracetamol (acetaminophen) and caffeine for the treatment of acute migraine attacks: A systemic review and meta-analysis of randomized placebo-controlled trials","volume":"29","author":"Diener","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/DDDT.S156509","article-title":"Efficacy and side effects of intravenous theophylline in acute asthma: A systematic review and meta-analysis","volume":"12","author":"Mahemuti","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Borea, P.A. (2018). The Adenosine Receptors, Springer International Publishing AG.","DOI":"10.1007\/978-3-319-90808-3"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/jpet.103.056036","article-title":"Antinociceptive effects of novel A2B adenosine receptor antagonists","volume":"308","author":"Hayallah","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.106.112250","article-title":"Effect of a specific and selective A2B adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma","volume":"320","author":"Mustafa","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/14737175.2021.1880896","article-title":"Istradefylline-A first generation adenosine A2A antagonist for the treatment of Parkinson\u2019s disease","volume":"21","author":"Jenner","year":"2021","journal-title":"Expert. Rev. Neurother."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Franco, R., Rivas-Santisteban, R., Navarro, G., and Reyes-Resina, I. (2021). Adenosine receptor antagonists to combat cancer and to boost anti-cancer chemotherapy and immunotherapy. Cells, 10.","DOI":"10.3390\/cells10112831"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gao, Z.-G., and Jacobson, K.A. (2019). A2B adenosine receptor and cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205139"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.coph.2020.08.003","article-title":"Targeting the A2AR in cancer; early lessons from the clinic","volume":"53","author":"Willingham","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"837230","DOI":"10.3389\/fimmu.2022.837230","article-title":"Adenosine-A2A receptor pathway in cancer immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108150","DOI":"10.1016\/j.intimp.2021.108150","article-title":"Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue","volume":"100","author":"Gavioli","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e202115545","DOI":"10.1002\/anie.202115545","article-title":"Single stabilizing point mutation enables high-resolution co-crystal structures of the adenosine A2A receptor with preladenant conjugates","volume":"61","author":"Claff","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature09665","article-title":"Structure and function of an irreversible agonist-\u03b22 adrenoceptor complex","volume":"469","author":"Rosenbaum","year":"2011","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cell.2017.01.042","article-title":"Structure of the adenosine A1 receptor reveals the basis for subtype selectivity","volume":"168","author":"Glukhova","year":"2017","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1021\/acs.jmedchem.9b00071","article-title":"A2B adenosine receptor antagonists with picomolar potency","volume":"62","author":"Jiang","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1021\/jm011049y","article-title":"1,8-disubstituted xanthine derivatives: Synthesis of potent A2B-selective adenosine receptor antagonists","volume":"45","author":"Hayallah","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/jm0310030","article-title":"Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: Toward the development of sulfonic acid prodrugs with peroral bioavailability","volume":"47","author":"Yan","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_21","first-page":"1639","article-title":"The impact of adenosine and A2B receptors on glucose homoeostasis","volume":"58","author":"Verspohl","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1021\/jm900413e","article-title":"1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity","volume":"52","author":"Borrmann","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-9717-6_3","article-title":"Agonists and antagonists for purinergic receptors","volume":"2041","author":"Baqi","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10822-009-9299-7","article-title":"Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor","volume":"23","author":"Sherbiny","year":"2009","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_25","unstructured":"Sealfon, S.C. (1995). [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Receptor Molecular Biology, Academic Press."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11302-016-9549-9","article-title":"A covalent antagonist for the human adenosine A2A receptor","volume":"13","author":"Yang","year":"2017","journal-title":"Purinergic Signal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1021\/acs.jmedchem.8b02026","article-title":"Development of covalent ligands for G protein-coupled receptors: A case for the human adenosine A3 receptor","volume":"62","author":"Yang","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1021\/jm00074a015","article-title":"Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: Structure-activity relationships at adenosine receptors","volume":"36","author":"Shi","year":"1993","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1016\/0040-4039(91)80214-Q","article-title":"Synthesis of 3-substituted 6-aminouracils","volume":"32","year":"1991","journal-title":"Tetrahedron Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-1993-25814","article-title":"General synthesis and properties of 1-monosubstituted xanthines","volume":"1993","year":"1993","journal-title":"Synthesis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-2001-11449","article-title":"Efficient synthesis of N-3-substituted 6-aminouracil derivatives via N6-[(dimethylamino)methylene] protection","volume":"2001","author":"Priego","year":"2001","journal-title":"Synthesis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1021\/acs.jmedchem.8b01153","article-title":"Emerging and re-emerging warheads for targeted covalent inhibitors: Applications in medicinal chemistry and chemical biology","volume":"62","author":"Gehringer","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/ml3001352","article-title":"Irreversible 4-aminopiperidine transglutaminase 2 inhibitors for Huntington\u2019s disease","volume":"3","author":"Prime","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/jm990421v","article-title":"Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors","volume":"43","author":"Kim","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bcp.2013.03.005","article-title":"The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors","volume":"85","author":"Seibt","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2010.07.009","article-title":"Structure based prediction of subtype-selectivity for adenosine receptor antagonists","volume":"60","author":"Katritch","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","article-title":"Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors","volume":"11","author":"Alnouri","year":"2015","journal-title":"Purinergic Signal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/acsptsci.2c00020","article-title":"Agonist-dependent coupling of the promiscuous adenosine A2B receptor to G\u03b1 protein subunits","volume":"5","author":"Voss","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","article-title":"TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome","volume":"16","author":"Olsen","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrd2877","article-title":"Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008","volume":"8","author":"Michino","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/prot.22507","article-title":"GPCR 3D homology models for ligand screening: Lessons learned from blind predictions of adenosine A2a receptor complex","volume":"78","author":"Katritch","year":"2010","journal-title":"Proteins"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.bmc.2014.06.050","article-title":"Synthesis and biological evaluation of pyrido2,3-dpyrimidine-2,4-dione derivatives as eEF-2K inhibitors","volume":"22","author":"Edupuganti","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1021\/jm7014815","article-title":"Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases","volume":"51","author":"Elzein","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1093\/nar\/gku1189","article-title":"New insights into the QuikChange\u2122 process guide the use of Phusion DNA polymerase for site-directed mutagenesis","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/12\/3792\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:28:39Z","timestamp":1760138919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/12\/3792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["molecules27123792"],"URL":"https:\/\/doi.org\/10.3390\/molecules27123792","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]}}}